Vaccines

(273) A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors

(280) Adapting to The Dynamic Landscape of the COVID-19 Pandemic: Proposed Study Design Approaches for a Postauthorization Safety Study for Pfizer-BioNTech COVID-19 Vaccine in the United States

(281) Adverse Events Following COVID-19 Immunization: Active Vaccine Safety Study from a South Indian City

(283) An Assessment of The Risk of Anaphylaxis Following Influenza Vaccination in The Korean Elderly: Implementing Near-Real Time Vaccine Safety Surveillance Methods

(263) Assessing The Effect of Statin Use on Influenza Vaccine Effectiveness: A Prior Event Rate Ratio Analysis in Primary Care Data

(262) Association Between Antibody Titer Levels, Time from COVID-19 Vaccine and Booster Receipt Among an Occupational Cohort of Fully Vaccinated Individuals

(264) Association Between Influenza Vaccination and The Risk of Acute Kidney Injury Among Older People in Korea: Self-Controlled Case Series Analysis

(247) Background Incidence Rates of Adverse Events of Special Interest for SARS-CoV-2 Vaccines Safety Monitoring in the US

(257) Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring Among Adults in the United States

(285) Capacity for Identifying Janssen Ad26.COV2.S COVID-19 Vaccination in Four US Health Insurance and State Immunization Information System Databases: Preparation for a Post Authorization Safety Study

(258) Cognitive and Other Neuropsychiatric Symptoms in COVID-19: Analysis of Person-Generated Health Data from a Community-Based Registry

(253) Combining COVID-19 Vaccine Data from Claims with Data from Immunization Information Systems (IIS) to Address Exposure Misclassification: An Approach Within the FDA Biologics Effectiveness and Safety (BEST) Initiative

(260) COVID Brain: The CARE Experience

(271) COVID-19 Booster Protection Against Incident Omicron Infection in a Highly Vaccinated Cohort

(295) COVID-19 Epidemiology, Prophylaxis and Treatment in The Africa Region

(254) COVID-19 Vaccine Hesitancy Among Health Care Workers: The Case of Pharmacy Staff of The Korle Bu Teaching Hospital

(272) Diabetics Report Fewer Side Effects from COVID-19 Vaccination Than Non-Diabetics in the US

(297) Distinguishing Patterns of Serious Adverse Events with mRNA COVID-19 Vaccines Using Vigibase: A Latent Class Analysis

(AR) Changing Characteristics Over Time of Individuals Receiving COVID-19 Vaccines in Denmark: A Population-Based Descriptive Study of Vaccine Uptake

(AN) Characteristics Associated with Residual Risk of COVID-19 Hospitalisation After a Complete Vaccination Schedule in 28 million People in France

(AS) Clinical Outcomes and Safety of Live-Attenuated Vaccines in Children Exposed to Biologics Response Modifiers in Utero

(AP) Cohort Monitoring of 29 Adverse Events of Special Interest Prior to and After COVID-19 Vaccination in Four Large European Data Sources

(AO) Heterogeneity Across European Electronic Healthcare Data Sources: Identification of Adverse Events of Special Interest (AESI) and Impact in Multi-Databases Assessment - An ACCESS Study

(AT) Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study Among Individuals in The Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine

(AU) Real-World Effectiveness of mRNA COVID-19 Vaccines Among Elderly U.S. Nursing Home Residents

(AQ) Vaccination and Acute Flares in Rheumatoid Arthritis: A Nationwide Case-Crossover Study Using the French SNDS Health Care Databases

(266) Evaluating The Effectiveness of Interventions to Improve Human Papillomavirus (HPV) Vaccine Uptake in Africa: A Systematic Review

(246) Experiences and Barriers of Community Pharmacists Towards Participation in COVID-19 Vaccination Campaigns

(249) Exploring The Impact of Mental Health Conditions on Vaccine Uptake in High-Income Countries

(255) Factors Associated with COVID-19 Vaccine Hesitancy in the United States

(259) Getting Prepared for COVID-19 Vaccines: How European Regulators Anticipated the Need for Real-World Evidence

(267) Hospitalizations After COVID-19 Vaccination: Self-Reported Patient Characteristics

(282) Immunization: Are We Confident or Hesitant?

(268) Increased SARS-CoV-2 Positivity Rates Among Individuals Tested at CVS Health Retail Sites During the Time of Delta and Omicron

(275) Influenza Vaccine and Risk of Myocardial Infarction in The Korean Elderly

(287) Knowledge About SARS-CoV-19 Booster Vaccines Among the General Public in India – A Web-based Cross-sectional Study

(291) Knowledge Build-Up on The Safety of EMA Approved COVID-19 Vaccines: An Overview

(251) Methodological Considerations for Matching Algorithms in Cohort Studies of COVID-19 Vaccine Effectiveness

(299) Monitoring of Adverse Events Following COVID-19 Vaccines in Department of Veterans Affairs

(290) Myocarditis and Pericarditis in Immunocompromised Individuals Following COVID-19 mRNA Vaccination: A Living Review of Spontaneous Reports

(270) Pfizer-BioNTech COVID-19 Vaccine and The Potential Risk of Hypoesthesia: Analysis of The Global and Local Individual Case Safety Reports

(277) Pneumococcal Serotype Distribution in Adults 65 Years and Older Around the World, 2011–2021

(276) Pneumococcal Serotype Distribution: Data in Pediatric Populations Under 5 Years Around the World, 2011–2021

(248) Prospective Monitoring of COVID-19 Vaccine Safety in the Republic of Croatia

(261) Real-World Safety of The Pfizer-BioNTech COVID-19 Vaccine in Pregnancy: Data from The Organization of Teratology Information Specialists (OTIS) Pregnancy Registry

(294) Reduction in Data Lag Using Optum Pre-Adjudicated Health Insurance Claims

(300) Risk of Myocarditis/Pericarditis After mRNA COVID-19 Vaccination in Commercial Insurance Claims

(256) Risk of Rhabdomyolysis After Influenza Vaccination: A Case-Centered Analysis

(288) Risk of SARS-CoV-2 Infection Following Initial COVID-19 Vaccination by Location

(274) Risk of Stroke Following Influenza Vaccination in Elderly: A National-Based Self-Controlled Case Series Study in Korea

(286) SARS-CoV-2 Breakthrough Infections Among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in The South Indian State of Kerala

(269) Self-Reported Demographics of Unvaccinated and Moderna Vaccinated Individuals Who Test Positive for SARS-CoV-2 at CVS Retail Sites

(279) Should We Worry About Flare-ups Following Vaccination in Systemic Lupus Patients? A Nationwide Case-Crossover Study Using the French Healthcare Database

(293) Side Effects of Vaccines Against COVID-19 in Valencia Region. Results of The ProVaVac Survey Study with 13,837 People in Spain

(296) Study of Myocarditis and Pericarditis Following Vaccination with COMIRNATY in Persons Under 21 Years of Age

(278) The Acceptability of Mixing Different Generic Types of COVID-19 Vaccine Among the General Population; A Cross Sectional Study in Saudi Arabia

(250) The Coverage of Influenza Vaccination and Predictors of Not Receiving the Influenza Vaccination in Danish Cancer Patients

(284) The Effectiveness of Single and Two-Dose Pfizer-BioNTech Vaccine: A Real-World Evidence from Saudi Arabia

(298) The Social Patterning of COVID-19 Vaccine Uptake in Older Adults: A Register-Based Study in Sweden Within The SCIFI-PEARL Project

(292) Tree-Based Data-Mining for COVID-19 Vaccine Safety Assessment

(301) VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results

(265) Vaccine Adverse Event Reporting System (VAERS): Evaluation of 31 Years of Reports and Pandemics Impact

(289) What Distinguishes People Who Experience Side Effects of COVID-19 Vaccines from Those Who Don't?